Dolby Laboratories, Inc.
DLB
$72.38
$0.931.30%
NYSE
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.39% | 34.79% | 39.52% | 30.48% | -3.09% |
| Total Depreciation and Amortization | 12.85% | 5.44% | -2.71% | -8.57% | -7.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.29% | -31.28% | -23.66% | -24.98% | 16.15% |
| Change in Net Operating Assets | 106.07% | -71.60% | 77.93% | -153.82% | -52.88% |
| Cash from Operations | 57.22% | 5.85% | 33.38% | -10.85% | -11.18% |
| Capital Expenditure | 10.81% | 6.35% | -5.02% | 1.09% | 6.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -2,003.43% | -2,003.43% | -1,998.13% | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,899.88% | 2,594.79% | 648.11% | 293.58% | -134.40% |
| Cash from Investing | -459.31% | -1,584.30% | -1,211.82% | -628.16% | -234.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -22.38% | -34.49% | -21.11% | -14.35% | 22.37% |
| Repurchase of Common Stock | 28.25% | 27.21% | 40.18% | -10.34% | 45.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.58% | -10.79% | -10.83% | -10.80% | -9.78% |
| Other Financing Activities | -166.83% | -1,334.38% | -1,311.37% | -1,869.19% | -488.38% |
| Cash from Financing | 10.05% | 3.20% | 18.99% | -21.54% | 38.02% |
| Foreign Exchange rate Adjustments | 494.04% | 26.48% | -314.68% | 29.69% | -181.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.43% | -156.53% | -225.68% | -226.70% | 69.84% |